LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Protocol No
SWOG-LUNGMAP
Phase
II/III
Summary

We are asking you to take part in this research study because you have non-small cell lung cancer. We are asking you to submit your tumor sample to test for specific genes and proteins. Based on the test results, you will be assigned to one of the treatment sub-studies.

Description
Targeted Treatment for Advanced Non-Small Cell Lung Cancer
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL